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Decavanadate, a vanadate oligomer, is known to interact with myosin and to inhibit the ATPase activity, but the putative binding sites and the
mechanism of inhibition are still to be clarified. We have previously proposed that the decavanadate (V10O28
6−) inhibition of the actin-stimulated
myosin ATPase activity is non-competitive towards both actin and ATP. A likely explanation for these results is that V10 binds to the so-called
back-door at the end of the Pi-tube opposite to the nucleotide-binding site. In order to further investigate this possibility, we have carried out
molecular docking simulations of the V10 oligomer on three different structures of the myosin motor domain of Dictyostelium discoideum,
representing distinct states of the ATPase cycle. The results indicate a clear preference of V10 to bind at the back-door, but only on the “open”
structures where there is access to the phosphate binding-loop. It is suggested that V10 acts as a “back-door stop” blocking the closure of the 50-
kDa cleft necessary to carry out ATP-γ-phosphate hydrolysis. This provides a simple explanation to the non-competitive behavior of V10 and
spurs the use of the oligomer as a tool to elucidate myosin back-door conformational changes in the process of muscle contraction.
© 2007 Elsevier B.V. All rights reserved.Keywords: Back-door; Decavanadate; Myosin; Molecular Docking1. Introduction
Myosin is a highly specialized protein involved in the process
of muscle contraction, which along with actin converts the
chemical energy of ATP hydrolysis into mechanical work. The
motor function of myosin is located on its globular head, the
subfragment-1 (S1), which contains both the nucleotide and
actin binding sites [1]. The triphosphate portion of ATP is tightly
bound in a tube-like structure, termed the Pi-tube, located at the
bottom of the active site [2,3]. On the basis of high-resolution X-
ray structures of the catalytic domain of Dictyostelium
discoideum myosin (S1dC) with several nucleotide analogues
[4–9], it has been proposed the existence of a secondary⁎ Corresponding author. Departamento de Química e Bioquímica, FCT,
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doi:10.1016/j.bbapap.2007.02.004entrance/exit to the active site at the rear opening of the Pi-tube
opposite to the “front door”. This “back-door” appears to be both
a likely approach route for a water molecule to attack the γ-
phosphate during ATP hydrolysis, and a likely exit route of the
cleaved γ-phosphate after hydrolysis [10,11]. The γ-phosphate
of ATP is partially visible in the structure of S1dC complexed
with MgADP·BeFx or MgATP, in which there is a clear opening
of the Pi-tube into the large cleft that divides the 50 kDa fragment
into upper and lower domains. In contrast, in the S1dC structures
complexed with MgADP·VO4 or MgADP·AlF4 the opening of
the Pi-tube is blocked off by a closure of the 50 kDa cleft and the
γ-phosphate is no longer visible (Fig. 1). The latter conforma-
tional change has been suggested to be necessary for the
hydrolysis of ATP [12–14] meaning that the phosphate group
will be trapped in the Pi-tube until a second conformational
rearrangement occurs, which was proposed to occur upon
myosin rebinding to actin [4]. Besides elucidating the kinetics of
ATP hydrolysis, this “back door” mechanism has been used to
explain a number of experimental observations, including the
Fig. 1. Back-door view of the structure of the S1 domain of Dictyostelium
discoideum myosin in complex with ATP (a) and MgADP·VO4 (b). The ATP
γ-phosphate group oxygen (in red) can be seen through the open back-door in
the S1·MgATP complex. Structures were obtained from the PDB; accession
numbers are given in Methods.
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muscle fibres [10].
The mechanism of inhibition of the myosin ATPase activity
by vanadate is relatively well characterized. Monomeric
vanadate (VO4
3−) mimics the transition state for the γ-phosphate
hydrolysis freezing myosin in a pre-power stroke state [15].
However, there is a considerably difference in the ability of
vanadate to inhibit the myosin and the actomyosin ATPase
activity. While in the absence of actin vanadate inhibits myosin
ATPase activity in the submicromolar concentration range, in
the presence of actin much higher concentrations (>900 μM)
are needed [16,17]. Clearly, the need for such high concentra-
tions strongly suggested that this effect could be due to
oligomeric vanadate species that are favored at higher vanadate
concentrations [18,19] and likely to occur through a different
mechanism. In fact it was recently shown that the ATPase
activity of the actomyosin complex is inhibited (Ki=0.27±
0.05 μM) by decameric but not by the monomeric form of
vanadate [20,21]. The results were consistent with binding of
decavanadate (V10) to the conserved regions of the phosphate
binding-loop (P-loop) which shape part of the Pi-tube [22]. This
V10 high-affinity binding site produces non-competitive inhibi-tion of the actin-stimulated S1-ATPase activity, without causing
dissociation of the ATP-free rigor acto-S1 complex. Moreover,
the affinity of S1 for V10 is modulated by the conformational
changes that takes place in S1 during the catalytic cycle, as
indicated by the two- to three-fold increase of the dissociation
constant produced in the presence of ADP·VO4 and ADP·AlF4
[21]. Two questions arose from this work: (1) how does V10
access the P-loop? (2) How can the V10 binding mode account
for non-competitive inhibition of the ATPase activity of the
actomyosin complex towards the nucleotide and actin?
In order to address the previous questions, we performed a
theoretical study in which decavanadate was docked in three
different myosin motor domain conformations representing
different intermediate states of the contractile cycle. The source
for these conformations were three X-ray structures of the D.
discoideum myosin S1 fragment, namely the apo (ligand-free)
form, and the S1dC·MgATP and S1dC·MgADP·VO4 com-
plexes [5,8]. The first two conformations considered (free and
ATP-bound) are quite similar and they both show an open
back-door conformation characteristic of the pre-hydrolysis
state. By binding at this site V10 could block the Pi-tube and
prevent ATP hydrolysis without competing with ATP or actin
for association with myosin. The third conformation is an
analogue of the transition state for ATP hydrolysis, and is
expected to bind V10 with lower affinity since the back-door is
in a closed conformation, rendering the P-loop inaccessible to
this ligand.
2. Methods
2.1. Selection and preparation of structures
Three D. discoideum myosin S1 structures were retrieved from the
Brookhaven Protein Databank: ligand-free (PDB code: 1FMV), in complex
with MgATP (PDB code: 1FMW) and in complex with MgADP·VO4 (PDB
code: 1VOM) [5,8]. The program Needle (EMBL-EBI site) was used to
calculate the percentage identity between the amino acid sequence of myosin II
from D. discoideum and from rabbit skeletal muscle using a global alignment
procedure. Several short loops, missing from the x-ray structures, were built and
optimized with the MODELLER software, following standard procedures [23].
All models were then validated with the PROCHECK software [24]. All
crystallographic water molecules were removed prior to the docking procedure.
2.2. Decavanadate and protein parameters
Coordinates for the decavanadate ion (V10O28
6−) were retrieved from the
Cambridge Structural Database. There are three non-equivalent positions for
vanadium atoms in decavanadate: two VA atoms lie at the center of the
equatorial plane, four VB atoms are in the equatorial plane and four VC atoms
lie in an axial position. Partial charges for all atoms were assigned after SCF
calculations of Kempf et al. [25]. These authors found that the inner vanadate
oxygens should be close to ionic state, with a charge of −2, while all other
oxygens would have charges close to −1. The remaining charge should be
evenly distributed among the 10 vanadium atoms. For the purpose of this work,
a charge of −2 was assigned to the OA and OB oxygen, a charge of −1 to all
remaining oxygen atoms, and a charge of +2.4 to the 10 vanadium atoms. The
non-bond parameters for vanadium were copied from the corresponding iron
values in the AutoDock library, a reasonable assumption given the similarity
between these two elements. Partial charges for the protein, MgATP and
MgADP atoms were taken from the Amber 95 forcefield library [26]. For the
VO4 ion, the total charge of −3 was evenly distributed among the four oxygen
atoms.
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All docking simulations were produced with the software AutoDock 3.0
[27], using Simulated Annealing algorithm (SA) and a total of 128 runs per
docked complex. Since no torsional degrees of freedom were assigned to
decavanadate, the SA docking algorithm was chosen because it performs better
in rigid-body docking situations. For the protein, the lack of conformational
flexibility is implied in the algorithm implemented in this version of the
AutoDock program.
The termination criterion for docking runs was either a maximum number
of 25,0000 energy evaluations or a maximum of 27,000 generations. The
docking trajectories were calculated within a cubic grid of size 36 Å and
spacing 0.3 Å centered on the active site and the final solutions were clustered
with a tolerance of 1.0 Å RMSD (root mean square deviation). Within each
cluster, solutions are ranked according to docking energies from lowest to
highest.3. Results
The docking of decavanadate was performed on the structure
of truncated D. discoideum myosin motor domain (S1dC)
because the crystallographic structure of rabbit skeletal myosin
has not been experimentally solved. Moreover, S1dC offers a
greater number of nucleotide-bound complexes with high
resolution compared to other myosins. At 43% sequence
identity, the two molecules have a sufficient degree of structural
similarity [28] to allow interpretation of the results here
presented on the basis of our previously published experimental
data on rabbit myosin.
The three myosin D. discoideum structures used in the
present work were chosen as they represent three distinct states
of the actomyosin ATP hydrolysis cycle relevant to the
interpretation of our previously published data on the interac-
tion between rabbit skeletal myosin S1 and decavanadate
[21,22]. The docking region is limited to a cube with side 36 Å
centered on the active site, since V10 is experimentally predicted
to bind in the vicinity of the catalytic center through the
phosphate-loop [22]. Docking calculations with the AutoDock
software were run on the three crystal structures, and the results
were evaluated in terms of the grouping (clustering) of solutions
found in each case. The number of solutions found in each
location (back- or front-door) and the lowest docking energy are
indicative of the stability of the complex and are displayed in
Table 1.Table 1
Molecular simulation results for decavanadate docking on the surface of the
nucleotide-free (Apo), MgATP and MgADP·VO4 structures of the S1 domain of
Dictyostelium discoideum myosin
No. of
solutions at
“Back-door”
No. of
solutions at
“Front-door”
No. of
solutions in
top cluster*
Lowest
energy
(Kcal mol−1)
Apo (1FMV) 89 2 48 −3.20
MgATP
(1FMW)
95 3 38 −2.02
MgADP·Vi
(1VOM)
0 79 14 −1.95
Protein coordinates were taken from the Brookhaven Protein Databank;
accession numbers are given in parenthesis. *Cluster with lower docking
energies.
Fig. 2. Resulting docked conformations of decavanadate (represented as sticks)
on the surface of the nucleotide-free (a), Mg·ATP (b) and Mg·ADP·VO4 (c)
structures of the S1 domain of Dictyostelium discoideum myosin. Docking was
performed as described in Methods. The back-door entrance and the nucleotide
binding site are on the left and right side of each structure, respectively.3.1. The apo-myosin structure
The crystal structure of S1dC myosin in its ligand-free (apo)
form is believed to be representative of the pre-hydrolysis state
after dissociation from actin [8]. The back-door is open in this
structural state (Fig. 1a), allowing V10 to easily access the P-
loop from this side. Of the 128 docking runs calculated for this
structure, 89 ended with V10 docked on the back-door (Table 1
and Fig. 2a) and 79 of these conformations were the lowest
477T. Tiago et al. / Biochimica et Biophysica Acta 1774 (2007) 474–480energy conformations, when compared to the remaining 49
runs. The lowest docking energy (in the back-door) was −3.20
kcal mol−1 (this energy value is only indicative, due to the
highly idiosyncratic nature of V10 when compared to the test set
used to parameterize Autodock). The preference thus shown by
V10 to bind at the back-door region leads support to our
previous finding that V10 does not compete with ATP for
binding to myosin [21,22]. Also, this location is consistent with
the non-competitive behavior of V10 towards actin binding to
myosin as it does not interfere with the actin binding interface.
A careful screening of the back-door solutions reveals
another feature correlated to our previous experimental
findings: back-door binding of V10 brings it very close to Ser-
181 (Fig. 3a), a residue located on the 178–185 sequence which
forms the phosphate binding-loop (P-loop) motive, previously
shown to be cleaved, upon irradiation, in the presence of V10
[22]. In the “front-door”, besides being farther from Ser-181
(11.84 Å) than in the back-door (6.27 Å for the lowest docked
energy conformation), the docked location of decavanadate is
partially shielded by side chains of other residues which would
prevent the access to Ser-181. One must note however that the
use of a rigid protein model in the docking procedure makes
these distances merely indicative.
3.2. The MgATP–myosin complex
The crystal structure of S1dC myosin complexed with ATP is
also an open back-door structure, very similar to the apo-S1dC
structure already discussed above. As pointed out by Bauer et al.
[8], this could explain the high affinity of myosin for ATP, and is
in agreement with this structure belonging to a pre-hydrolysis
state, and thus unable to hydrolyze ATP. Given the extent of
structural similarity, it is no surprise that the docking results are
very similar to those obtained with the apo-S1dC structure. Of
the 128 docking runs, 95 ended with V10 docked in the back-Fig. 3. Lowest energy docked conformations of V10 on: (a) the back-door (left) and
domain of Dictyostelium discoideum; (b) the S1dC structure in complex with Mg·AT
The P-loop, switch I and switch II segments forming the phosphate-tube are repr
represented as spheres.door region, and 62 of theses conformations were the solutions
with lower energy (Table 1 and Fig. 2b). The lowest energy for a
docked conformation was slightly higher than in the apo-S1dC
docking (−2.02 kcal/mol), as expected because of the repulsion
between the negative charge of V10 and ATP (however, see the
previous remark on the significance of Autodock energies). The
preference for V10 binding at the back-door is again clear, in
spite of the electrostatic effect of ATP at the active site. This
result agrees well with the experimentally observed non-
competitive effect of V10 towards myosin ATP hydrolysis
[21]. The most stable conformation of V10 is again close to Ser-
181, but not as close as in the apo-S1dC dockings (Fig. 3b). This
increased distance (approximately 2 Å for the lowest energy
conformations) could explain why only partial V10 photo-
cleavage of myosin is attained in the presence of nucleotide [22].
3.3. The MgADP·VO4–myosin complex
The S1dC–MgADP–VO4 crystal structure is believed to be
representative of the post-hydrolysis transient state before the
power-stroke [5,29,30]. In this state, the 50-kDa cleft has
closed (Fig. 1b), blocking the Pi-tube and preventing both the
release of Pi and the access of V10 to the back-door and
consequently the P-loop. Accordingly, out of the 128
simulation runs there were 79 final V10 conformations docked
at the entrance of the ATP-binding site (“front-door”), and these
were the lowest energy solutions (Table 1 and Fig. 2c). With
the access to the P-loop barred, binding at the back-door region
no longer represents an energetically favorable solution, and
the front door remains as the only favorable solution for
docking V10 on the myosin surface. The smaller stabilization
offered by binding at the nucleotide site could explain the
experimentally observed two- to three-fold increase for the dis-
sociation constant of the V10–myosin complex in the presence
of ADP·VO4 or ADP·AlF4 (another analogue of the transitionnucleotide binding pocket (right) regions of the ligand-free structure of the S1
P. Serine 181 is colored green in both structures; ATP is yellow and Mg2+ violet.
esented in orange, cyan and pink, respectively. V10, Mg·ATP and Ser181 are
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similar to the ADP·VO4 structure) [21]. Therefore, if different
conformational states of myosin display different affinities for
V10, it is expected that an altered distribution of conforma-
tional states during the steady state catalytic activity takes
place in the presence of V10.
4. Discussion
The computational molecular docking calculations presented
here, together with previous experimental data, lend strong
support for the binding of V10 at the back-door of the S1dC
myosin fragment in the free or pre-hydrolysis nucleotide-bound
state. This binding location both explains how the 10 Å
decavanadate molecule gains access to the P-loop without
having to squeeze through the narrow entrance of the
phosphate-tube at the nucleotide binding site, and provides a
simple mechanism for the experimentally observed non-
competitive pattern of inhibition of V10 towards binding of
both ATP and actin to myosin. By binding at the back-door, at
the end of the Pi-tube, V10 will not interfere with the nucleotide
binding site or the actin binding surface. Photo-cleavage of
myosin by V10 at the Ser-181 position can also be accounted for,
since the lowest energy docked solutions of V10 at the back-
door place it in very close contact with this residue. Binding of
V10 to the back-door is also supported by the experimentally
observed strong quenching of IAEDANS fluorescence by V10
[21], when the probe is bond to a cysteine residue close to theFig. 4. Relevant steps of the actomyosin ATP hydrolysis cycle schematically represe
promotes opening of the 50-kDa cleft leading to dissociation of the actomyosin comp
and a conformational change of the S1 domain (c). At this point, the back-door is c
rebinds actin, leading to the opening of the back-door and Pi release (d). When pr
concomitant closure of the back-door thus preventing ATP hydrolysis.back-door (Cys697). Also consistent with this picture is the
previously observed competition of V10 binding with AP5A
[21], a γ-phosphate modified nucleotide analogue that has been
shown to bind myosin in a bimodal way that extends from the
catalytic crevice through the Pi-tube and to the 50 kDa cleft
leading to the back-door [31]. However, the question still
remains: at which step in the actomyosin ATPase cycle does V10
bind to myosin?
Since the closed states of myosin display low affinity for
V10, binding must take place when the back-door is open, either
at the pre-hydrolysis or the “power-stroke” states of the
actomyosin ATP hydrolysis cycle. In the latter state myosin is
strongly bound to actin, so V10 would have to interfere with
formation of the transient acto-myosin complex. However, we
have previously shown by light-scattering studies that V10
binding does not dissociate the ATP-free rigor acto-myosin
complex [21]. On the other hand, these experimental results
indicated a positive correlation between the time after addition of
ATP needed for the re-association of actin to myosin in the
presence of V10 and the extent of V10 inhibition of the acto-
myosin ATPase activity. Besides, decavanadate addition with
MgADP is without effect on the actomyosin complex. Together,
these results show that while V10 does not promote dissociation
of the acto-myosin complex, it does prevent its formation until
ATP level in the solution is sufficiently low for the re-association
process to occur. Consequently, V10 must bind to myosin at its
dissociated state, most likely the pre-hydrolysis state after actin
release and before closure of the 50 kDa cleft and concomitantlynted as perturbed by V10 binding: ATP binding to myosin in the rigor state (a)
lex (b). In the absence of V10, closure of the active site leads to ATP hydrolysis
losed and the hydrolyzed Pi group is trapped inside the active site until myosin
esent, V10 acts as “back-door stop”, blocking closure of the 50-kDa cleft and
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“back-door stop” blocking the conformational change necessary
to carry out the ATP-γ-phosphate hydrolysis. This proposal is
schematically represented in Fig. 4. When attempting to
extrapolate the myosin behavior in muscle fibers from the
above proposal, one must keep in mind that all structures used in
this work are static intermediates, frozen snapshots taken out of
the conformational complexity of myosin in solution. As such,
there may be other transient states, as of yet unknown, playing a
key role in the myosin cycle in vivo.
Very often studies describing interactions of vanadate with
proteins consider only monomeric vanadate as the active
species, disregarding the possible contribution of other vanadate
oligomers which are favored at higher vanadate concentrations
[18,19]. Unlike the simple and labile vanadate oligomers
including monomeric (V1), dimeric (V2), tetrameric (V4) and
pentameric (V5) species, which interchange with each other on
the millisecond to second time scale in neutral and alkaline
aqueous solutions, decameric species (V10) interconversion
with the other vanadate oligomers occurs on a considerably
longer time scale [32]. Although above pH 6 decavanadate is not
the most thermodynamically stable species, it can persist for
limited time periods because hydrolysis into other vanadate
oligomers is very slow which makes it an excellent molecular
probe to investigate the nature of polyoxoanions interactions
with proteins. Among the free or complexed forms of vanadate,
decameric species is one of the most potent inhibitors. The
enzymes inhibited by decavanadate appear to be all prearranged
to bind phosphoryl groups, but V10 is structurally different from
V1 and cannot mimic orthophosphate in its interaction with
enzymes. Moreover, decavanadate inhibition is by no means a
general property of all the enzymes that bind phosphoryl groups
and therefore the structural and conformational characteristics of
the enzymes must be important. For example, Pezza et al. [33]
have shown that the Walker A motive of ABC ATPases is a
highly adapted anion-binding domain that can bind decavana-
date with high affinity. Unlike V1, decavanadate interacts
outside the Walker A loop (corresponding to the P-loop in
myosin) and is stabilized by certain residues nearby. Therefore,
according to these authors, if the presence of these residues is
essential for the binding stabilization, only some members of the
ABC superfamily are able to interact with decavanadate.
In what concerns myosin, vanadate is able to populate
different conformational states of the myosin ATPase cycle
depending on its oligomerization state. While monomeric
vanadate (VO4
3−) mimics the transition state for the γ-phosphate
hydrolysis blocking myosin in a pre-power-stroke state,
decameric vanadate induces the formation of the intermediate
myosin·MgATP·V10 complex blocking the actomyosin cycle
presumably in the pre-hydrolysis state. Therefore, the mode of
action of vanadate on the inhibition of the actin-stimulated
myosin ATPase activity depends, at least in part, on the charge
and size of the vanadate species, being favored for those with
higher oligomerization state, such as the decameric species. The
specific phosphate-binding domains in the vicinity of the back-
door provide electrostatic interactions which favor an approach
of this polyanionic species to the rear opening of the Pi-tube. Inaddition, the large size of decavanadate is likely to interfere with
movements associated with closure of the 50–kDa cleft and
concomitant closure of the back-door. This allows rationalizing
on simple grounds (1) the non-competitive inhibition of V10
towards both actin and ATP of the actin-stimulated myosin-
ATPase activity; (2) the delayed re-association of the actomyo-
sin complex but without a dissociation of the ATP-free rigor
complex in the presence of decavanadate; (3) the preference of
V10 to bind at the back-door entrance of the Pi-tube, but only on
the “open” structures were there is access to the phosphate
binding-loop. Finally, this study lends further support to the
myosin back-door mechanism hypothesis and spurs the use of
decavanadate as a biochemical tool to gain a deeper knowledge
of the myosin back-door modulation and the relevance of its
conformational changes in the process of muscle contraction.
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